Modulation of buspirone HCl release from hypromellose matrices using chitosan succinate: Implications for pH-independent release

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 70, Issue 3, 2008, Pages 804-812

  AlKhatib, Hatim S ^a   Aiedeh, Khaled M ^a   Bustanji, Yasser ^a   Hamed, Saja ^b   Mohammad, M K ^a   AlKhalidi, Bashar ^a   Najjar, Samer ^c  

^a UNIVERSITY OF JORDAN   (Jordan)

^b HASHEMITE UNIVERSITY   (Jordan)

^c Sana Pharmaceutical Research Co   (Jordan)

Author keywords

Buspirone HCl; Chitosan succinate; Complex formation; Dialysis studies; Dissolution similarity; HPMC tablets; pH Independent release

Indexed keywords

BUSPIRONE; CHITOSAN DERIVATIVE; CHITOSAN SUCCINATE; HYDROXYPROPYLMETHYLCELLULOSE; SUCCINIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; COMPLEX FORMATION; CONTROLLED DRUG RELEASE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG GRANULATION; DRUG SOLUBILITY; DRUG STABILITY; ION EXCHANGE; IONIC STRENGTH; PH; QUANTITATIVE ANALYSIS; SYNTHESIS;

BUSPIRONE; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DRUG CARRIERS; DRUG COMPOUNDING; KINETICS; METHYLCELLULOSE; OSMOLAR CONCENTRATION; SODIUM CHLORIDE; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; TABLETS; TECHNOLOGY, PHARMACEUTICAL;

EID: 54949128607     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.06.017     Document Type: Article

References (38)

1. Colombo P., Bettini R., Santi P., and Peppas N.A. Swellable matrixes for controlled drug delivery: gel-layer behavior, mechanisms and optimal performance. Pharm. Sci. Technol. Today 3 6 (2000) 198-204
2. Nokhodchi A., and Rubinstein M.H. An overview of the effects of material and process variables on the compaction and compression properties of hydroxypropyl methylcellulose and ethylcellulose. STP Pharma Sci. 11 3 (2001) 195-202
3. Siepmann J., and Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 48 2-3 (2001) 139-157
4. Li C.L., Martini L.G., Ford J.L., and Roberts M. The use of hypromellose in oral drug delivery. J. Pharm. Pharmacol. 57 5 (2005) 533-546
5. Siepe S., Lueckel B., Kramer A., Ries A., and Gurny R. Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH. Int. J. Pharm. 316 1-2 (2006) 14-20
6. Hörter D., and Dressman J.B. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug Deliv. Rev. 46 1-3 (2001) 75-87
7. Fu X.C., Wang G.P., Liang W.Q., and Chow M.S.S. Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration. J. Control. Release 95 2 (2004) 209-216
8. Furlanetto S., Cirri M., Maestrelli F., Corti G., and Mura P. Study of formulation variables influencing the drug release rate from matrix tablets by experimental design. Eur. J. Pharm. Biopharm. 62 1 (2006) 77-84
9. Streubel A., Siepmann J., Dashevsky A., and Bodmeier R. pH-Independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets. J. Control. Release 67 1 (2000) 101-110
10. Takka S., Rajbhandari S., and Sakr A. Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets. Eur. J. Pharm. Biopharm. 52 1 (2001) 75-82
11. Tatavarti A.S., and Hoag S.W. Microenvironmental pH modulation based release enhancement of a weakly basic drug from hydrophilic matrices. J. Pharm. Sci. 95 7 (2006) 1459-1468
12. Rao V.M., Engh K., and Qiu Y. Design of pH-independent controlled release matrix tablets for acidic drugs. Int. J. Pharm. 252 1-2 (2003) 81-86
13. Takka S. Propranolol hydrochloride-anionic polymer binding interaction. Il Farmaco 58 (2003) 1051-1056
14. Tatavarti A.S., Mehta K.A., Augsburger L.L., and Hoag S.W. Influence of methacrylic and acrylic acid polymers on the release performance of weakly basic drugs from sustained release hydrophilic matrices. J. Pharm. Sci. 93 9 (2004) 2319-2331
15. Elkheshen S.A. Interaction of verapamil hydrochloride with Carbopol 934P and its effect on the release rate of the drug and the water uptake of the polymer matrix. Drug Dev. Ind. Pharm. 27 9 (2001) 925-934
16. Bommareddy G.S., Paker-Leggs S., Saripella K.K., and Neau S.H. Extruded and spheronized beads containing Carbopol 974P to deliver nonelectrolytes and salts of weakly basic drugs. Int. J. Pharm. 321 1-2 (2006) 62-71
17. Bonferoni M.C., Rossi S., Ferrari F., Bettinetti G.P., and Caramella C. Characterization of a diltiazem-lambda carrageenan complex. Int. J. Pharm. 200 (2000) 207-216
18. Bonferoni M.C., Rossi S., Ferrari F., and Caramella C. Development of oral controlled-release tablet formulations based on diltiazem-carrageenan complex. Pharm. Dev. Technol. 9 2 (2004) 155-162
19. Moreno-Villoslada I., Oyarzun F., Miranda V., Hess S., and Rivas B.L. Binding of chlorpheniramine maleate to pharmacologically important alginic acid, carboxymethylcellulose, κ-carrageenan, and l-carrageenan as studied by diafiltration. J. Appl. Polym. Sci. 98 2 (2005) 598-602
20. Bonferoni M.C., Sandri G., Gavini E., Rossi S., Ferrari F., and Caramella C. Microparticle systems based on polymer-drug interaction for ocular delivery of ciprofloxacin I. In vitro characterization. J. Drug Deliv. Sci. Tec. 17 1 (2007) 57-62
21. Ramirez Rigo Maria V., Allemandi Daniel A., and Manzo Ruben H. A linear free energy relationship treatment of the affinity between carboxymethylcellulose and basic drugs. Mol. Pharm. 1 5 (2004) 383-386
22. Aiedeh K.M., Taha M.O., and Al-Khatib H. Evaluation of chitosan succinate and chitosan phthalate as enteric coating polymers for diclofenac sodium tablets. J. Drug Deliv. Sci. Tec. 15 3 (2005) 207-211
23. Thanou M., Verhoef J.C., and Junginger H.E. Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Deliv. Rev. 52 2 (2001) 117-126
24. Aiedeh K.M., Al Khatib H., Taha M.O., and Al-Zoubi N. Application of novel chitosan derivatives in dissolution enhancement of a poorly water soluble drug. Pharmazie 61 4 (2006) 306-311
25. Jonker-Venter C., Snyman D., van Rensburg J., Jordaan E., Schultz C., Steenekamp J.H., Hamman J.H., and Kotze A.F. Low molecular weight quaternized chitosan (II): in vitro assessment of absorption enhancing properties. Pharmazie 61 4 (2006) 301-305
26. Zambito Y., Uccello-Barretta G., Zaino C., Balzano F., and Di Colo G. Novel transmucosal absorption enhancers obtained by aminoalkylation of chitosan. Eur. J. Pharm. Sci. 29 5 (2006) 460-469
27. Aiedeh K.M., Taha M.O., Al-Hiari Y., Bustanji Y., and Alkhatib H.S. Effect of ionic crosslinking on the drug release properties of chitosan diacetate matrices. J. Pharm. Sci. 96 1 (2007) 38-43
28. Atyabi F., Majzoob S., Dorkoosh F., Sayyah M., and Ponchel G. The impact of trimethyl chitosan on in vitro mucoadhesive properties of pectinate beads along different sections of gastrointestinal tract. Drug Dev. Ind. Pharm. 33 3 (2007) 291-300
29. Aiedeh K., and Taha M.O. Synthesis of chitosan succinate and chitosan phthalate and their evaluation as suggested matrixes in orally administered colon-specific drug delivery systems. Arch. Pharm. 332 3 (1999) 103-107
30. Aiedeh K., and Taha M.O. Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral theophylline sustained-release beads. Eur. J. Pharm. Sci. 13 2 (2001) 159-168
31. Ubaidulla U., Kishan Khar R., Jalees Ahmad F., Sultana Y., and Kumar Panda A. Development and characterization of chitosan succinate microspheres for the improved oral bioavailability of insulin. J. Pharm. Sci. 96 11 (2007) 3010-3023
32. Sandri G., Cristina Bonferoni M., Chetoni P., Rossi S., Ferrari F., Ronchi C., and Caramella C. Ophthalmic delivery systems based on drug-polymer-polymer ionic ternary interaction: in vitro and in vivo characterization. Eur. J. Pharm. Biopharm. 62 1 (2006) 59-69
33. FDA, Dissolution Testing of Immediate Release Solid Oral Dosage Forms, Guidance for Industry, 1997.
34. Costa P., and Sousa Lobo J.M. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 13 2 (2001) 123-133
35. March J. Advanced Organic Chemistry. fourth ed. (1992), John Wiley and Sons, New York pp. 377-378
36. Rinaki E., Valsami G., and Macheras P. The power law can describe the'entire' drug release curve from HPMC-based matrix tablets: a hypothesis. Int. J. Pharm. 255 1-2 (2003) 199-207
37. Qiu Y., Hui H.-W., and Cheskin H. Formulation development of sustained-release hydrophilic matrix tablets of zileuton. Pharm. Dev. Tec. 2 3 (1997) 197-204
38. De Brabander C., Vervaet C., and Remon J.P. Development and evaluation of sustained release mini-matrices prepared via hot melt extrusion. J. Control. Release 89 2 (2003) 235-247